KDKatie Drax

Katie Drax

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Katie Drax has a total of 92 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Discrepancy review: A feasibility study of a novel peer review intervention to reduce undisclosed discrepancies between registrations and publications

    by TARG Meta-Research Group & Collaborators, Robert T. Thibault, Tom E. Hardwicke, Robbie W. A. Clark, Charlotte R. Pennington, Gustav Nilsonne, Aoife O'Mahony, Katie Drax, Jacqueline Thompson, Marcus R. Munafò

    Background: Undisclosed discrepancies often exist between study registrations and their associated publications. Discrepancies can increase risk of bias, and when undisclosed, they disguise this increased risk of bias from readers. To remedy this issue, we developed an intervention called discrepancy review . We provided journals with peer reviewers specifically assigned to check for undisclosed discrepancies between registrations and manuscripts submitted to journals. Objectives: We aimed to (1) evaluate the feasibility of incorporating discrepancy review as a regular practice at scientific journals and the feasibility of conducting a trial on discrepancy review; (2) explore the benefits and time required to incorporate discrepancy review as a regular practice at scientific journals; and (3) refine the discrepancy review process. Method: We performed discrepancy review on 18 manuscripts submitted to Nicotine and Tobacco Research and 3 manuscripts submitted to the European Journal of Personality . We iteratively refined the discrepancy review process based on feedback from discrepancy reviewers, editors, and authors. We then assessed whether revised manuscripts addressed recommendations from discrepancy reviewers and identified potential outcome measures for use in a future trial of discrepancy review. Results: Registrations were generally too imprecise to be effectively evaluated by our original discrepancy review process so we developed a simplified, semi-structured process. Authors addressed the majority of discrepancy reviewer comments and there was no opposition to running a trial from authors, editors, or discrepancy reviewers. Clinical trial registrations were more precise but less comprehensive than registrations on the Open Science Framework, suggesting they should be evaluated in separate trials. Outcome measures for a trial of discrepancy review on clinical trial registration could include the presence of primary or secondary outcome discrepancies and whether publications that are not the primary report from a clinical trial registration are clearly described as such. Outcome measures for a trial on Open Science Framework registrations could include assessments of whether registrations are permanent, as well as an overarching subjective assessment of the impact of discrepancies. Conclusion: We found that discrepancy review could feasibly be introduced as a regular practice at journals interested in this process. A full trial of discrepancy review would be needed to evaluate its impact on reducing undisclosed discrepancies.

  • Open Access

    Evaluating Registered Reports Funding Partnerships: a feasibility study

    by Robbie Clark, Katie Drax, Christopher D. Chambers, Marcus Munafò, Jacqueline Thompson

    Background: We studied a novel initiative – Registered Reports Funding Partnerships (RRFPs) – whereby research funders and journals partner in order to integrate their procedures for funding applications and Registered Reports submissions into one process. We investigated the feasibility of conducting a randomised controlled trial (RCT) of the impact of RRFPs on (1) research quality and (2) the efficiency of the research process, from funding to publication. Methods: We conducted 32 semi-structured interviews and follow-up questionnaires with stakeholders (funders, editors, authors, and reviewers) across six different RRFPs. Results: A RCT of RRFPs appears to be feasible in principle. The partnership concept seems worthwhile to pursue further and is adaptable to the needs of various funders and publishers, and across disciplines. Three primary outcomes of interest should be measurable, and participant randomisation could conceivably be done in a number of ways. In practice, however, the current volume of submissions going through existing partnerships is too low to support a full trial. Conclusions: Although a RCT of RRFPs is conceptually feasible, it will only be possible if organisations are willing to form new partnerships, scale up existing ones, and incorporate a trial (i.e., randomisation) into these partnerships.


  • Open Access

    A qualitative analysis of stakeholder experiences with Registered Reports Funding Partnerships

    by Katie Drax, Robbie Clark, Christopher D. Chambers, Marcus Munafò, Jacqueline Thompson

    Background: Registered Reports (RRs) could be a way to increase the quality of scientific research and literature, such as by reducing publication bias and increasing the rigour of study designs. These potential benefits have led to Registered Report funding partnerships (RRFPs or partnerships for short) between research funders and academic journals who collaborate to encourage researchers to publish RRs. In this study we investigated the research question: “What are the experiences of the stakeholders (authors, reviewers, journal editors, funders) in the various partnership models?”. Our companion paper addresses a related, but separate, research question. Methods: We conducted a thematic analysis of 32 semi-structured interviews with stakeholders (funders, editors, authors, reviewers, matchmakers) from six partnerships. Results: Interviewees had highly variable perceptions and experiences, reflecting the complex and nuanced impacts of partnerships. We identified 6 themes: “Importance of communication with authors and reviewers”, “Influence on study design”, “Appropriateness of partners”, “Potential to reduce publication bias”, “Impact on reviewer workload”, and “Insufficient evidence”. Conclusions: This was the first investigation into these novel initiatives. We hope that our findings can benefit and shape current and future partnerships.


  • Open Access

    Building a Systematic Online Living Evidence Summary of COVID-19 Research

    by Kaitlyn Hair, Emily S. Sena, Emma Wilson, Gillian Currie, Malcolm Macleod, Zsanett Bahor, Chris Sena, Can Ayder, Jing Liao, Ezgi Tanriver Ayder, et al.

    Throughout the global coronavirus pandemic, we have seen an unprecedented volume of COVID-19 researchpublications. This vast body of evidence continues to grow, making it difficult for research users to keep up with the pace of evolving research findings. To enable the synthesis of this evidence for timely use by researchers, policymakers, and other stakeholders, we developed an automated workflow to collect, categorise, and visualise the evidence from primary COVID-19 research studies. We trained a crowd of volunteer reviewers to annotate studies by relevance to COVID-19, study objectives, and methodological approaches. Using these human decisions, we are training machine learning classifiers and applying text-mining tools to continually categorise the findings and evaluate the quality of COVID-19 evidence.


  • Open Access

    Is useful research data usually shared? An investigation of genome-wide association study summary statistics

    by Mike Thelwall, Marcus Munafò, Amalia Mas-Bleda, Emma Stuart, Meiko Makita, Verena Weigert, Chris Keene, Nushrat Khan, Katie Drax, Kayvan Kousha

    Primary data collected during a research study is often shared and may be reused for new studies. To assess the extent of data sharing in favourable circumstances and whether data sharing checks can be automated, this article investigates summary statistics from primary human genome-wide association studies (GWAS). This type of data is highly suitable for sharing because it is a standard research output, is straightforward to use in future studies (e.g., for secondary analysis), and may be already stored in a standard format for internal sharing within multi-site research projects. Manual checks of 1799 articles from 2010 and 2017 matching a simple PubMed query for molecular epidemiology GWAS were used to identify 314 primary human GWAS papers. Of these, only 13% reported the location of a complete set of GWAS summary data, increasing from 3% in 2010 to 23% in 2017. Whilst information about whether data was shared was typically located clearly within a data availability statement, the exact nature of the shared data was usually unspecified. Thus, data sharing is the exception even in suitable research fields with relatively strong data sharing norms. Moreover, the lack of clear data descriptions within data sharing statements greatly complicates the task of automatically characterising shared data sets.


  • Open Access

    Is useful research data usually shared? An investigation of genome-wide association study summary statistics

    by Mike A. Thelwall, Marcus Munafò, Amalia Mas Bleda, Emma Stuart, Meiko Makita, Verena Weigert, Chris Keene, Nushrat Khan, Katie Drax, Kayvan Kousha

    Primary data collected during a research study is increasingly shared and may be re-used for new studies. To assess the extent of data sharing in favourable circumstances and whether such checks can be automated, this article investigates the summary statistics of primary human genome-wide association studies (GWAS). This type of data is highly suitable for sharing because it is a standard research output, is straightforward to use in future studies (e.g., for secondary analysis), and may be already stored in a standard format for internal sharing within multi-site research projects. Manual checks of 1799 articles from 2010 and 2017 matching a simple PubMed query for molecular epidemiology GWAS were used to identify 330 primary human GWAS papers. Of these, only 10.6% reported the location of a complete set of GWAS summary data, increasing from 4.3% in 2010 to 16.8% in 2017. Whilst information about whether data was shared was usually located clearly within a data availability statement, the exact nature of the shared data was usually unspecified. Thus, data sharing is the exception even in suitable research fields with relatively strong norms regarding data sharing. Moreover, the lack of clear data descriptions within data sharing statements greatly complicates the task of automatically characterising shared data sets.

  • Open Access

    Informing drinkers: Can current UK alcohol labels be improved?

    by Anna K.M. Blackwell, Katie Drax, Angela S. Attwood, Marcus R. Munafò, Olivia M. Maynard